In lung cancer, CCL20-mediated MEK signaling was shown to mediate proliferation [40] and migration [40], while in breast cancer CCL20-mediated MEK signaling was shown to mediate proliferation [41]. The gene discussed is MAP2K7; the disease is breast carcinoma.